Biochemistry · 2014 · 66 citations · 6 references
MedicineOncologyPharmacologyCancer PharmacologyDrug DeliveryMolecular ImagingAntibody ConjugatesCancer GlycobiologyMacromolecular InteractionsOncology PharmacologyTargeted Cancer TherapyCancer Targeting LigandsCellular Uptake ModulationGlycan-based Cancer TherapeuticsTargeting Ligand ConjugationTumor Cell InteractionsTumor Cell SelectivityTumor Targeting LigandsTumor-targeted Ligands
Recently, we reported that both bleomycin (BLM) and its disaccharide, conjugated to the cyanine dye Cy5**, bound selectively to cancer cells. Thus, the disaccharide moiety alone recapitulates the tumor cell targeting properties of BLM. Here, we demonstrate that the conjugate of the BLM carbamoylmannose moiety with Cy5** showed tumor cell selective binding and also enhanced cellular uptake in most cancer cell lines. The carbamoyl functionality was required for tumor cell targeting. A dye conjugate prepared from a trivalent cluster of carbamoylmannose exhibited levels of tumor cell binding and internalization significantly greater than those of the simple carbamoylmannose-dye conjugate, consistent with a possible multivalent receptor.
6
New antibiotics, bleomycin A and B.
Hitoshi Umezawa, Kazuhiko Maeda, Tsutomu Takeuchi et al. · PubMed · 1966 · 732 citations
Dale L. Boger, Takeshi Honda · Journal of the American Chemical Society · 1994 · 118 citations